Annual Total Liabilities
$26.88 M
-$5.35 M-16.60%
31 December 2023
Summary:
Y-mAbs Therapeutics annual total liabilities is currently $26.88 million, with the most recent change of -$5.35 million (-16.60%) on 31 December 2023. During the last 3 years, it has risen by +$673.00 thousand (+2.57%). YMAB annual total liabilities is now -17.73% below its all-time high of $32.68 million, reached on 31 December 2021.YMAB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$28.49 M
-$20.21 M-41.50%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly total liabilities is currently $28.49 million, with the most recent change of -$20.21 million (-41.50%) on 30 September 2024. Over the past year, it has dropped by -$246.00 thousand (-0.86%). YMAB quarterly total liabilities is now -41.50% below its all-time high of $48.70 million, reached on 30 June 2024.YMAB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.6% | -0.9% |
| 3 y3 years | +2.6% | -2.2% |
| 5 y5 years | +135.9% | +60.5% |
YMAB Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.7% | +2.6% | -41.5% | +18.1% |
| 5 y | 5 years | -17.7% | +135.9% | -41.5% | +63.1% |
| alltime | all time | -17.7% | +417.0% | -41.5% | +266.3% |
Y-mAbs Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.49 M(-41.5%) |
| June 2024 | - | $48.70 M(+101.9%) |
| Mar 2024 | - | $24.13 M(-10.3%) |
| Dec 2023 | $26.88 M(-16.6%) | $26.88 M(-6.4%) |
| Sept 2023 | - | $28.73 M(+3.7%) |
| June 2023 | - | $27.71 M(-6.4%) |
| Mar 2023 | - | $29.62 M(-8.1%) |
| Dec 2022 | $32.23 M(-1.4%) | $32.23 M(-10.5%) |
| Sept 2022 | - | $36.02 M(+6.6%) |
| June 2022 | - | $33.78 M(+0.6%) |
| Mar 2022 | - | $33.58 M(+2.7%) |
| Dec 2021 | $32.68 M | $32.68 M(+12.2%) |
| Sept 2021 | - | $29.13 M(+15.8%) |
| June 2021 | - | $25.16 M(+10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $22.70 M(-13.4%) |
| Dec 2020 | $26.21 M(+50.1%) | $26.21 M(-1.8%) |
| Sept 2020 | - | $26.68 M(+25.1%) |
| June 2020 | - | $21.32 M(+13.7%) |
| Mar 2020 | - | $18.74 M(+7.3%) |
| Dec 2019 | $17.46 M(+53.2%) | $17.46 M(-1.6%) |
| Sept 2019 | - | $17.75 M(+0.5%) |
| June 2019 | - | $17.66 M(+21.9%) |
| Mar 2019 | - | $14.48 M(+27.1%) |
| Dec 2018 | $11.40 M(+14.3%) | $11.40 M(+0.3%) |
| Sept 2018 | - | $11.37 M(+46.1%) |
| June 2018 | - | $7.78 M(-22.0%) |
| Dec 2017 | $9.97 M(+91.8%) | $9.97 M |
| Dec 2016 | $5.20 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual total liabilities year-on-year change?
- What is Y-mAbs Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly total liabilities year-on-year change?
What is Y-mAbs Therapeutics annual total liabilities?
The current annual total liabilities of YMAB is $26.88 M
What is the all time high annual total liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total liabilities is $32.68 M
What is Y-mAbs Therapeutics annual total liabilities year-on-year change?
Over the past year, YMAB annual total liabilities has changed by -$5.35 M (-16.60%)
What is Y-mAbs Therapeutics quarterly total liabilities?
The current quarterly total liabilities of YMAB is $28.49 M
What is the all time high quarterly total liabilities for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total liabilities is $48.70 M
What is Y-mAbs Therapeutics quarterly total liabilities year-on-year change?
Over the past year, YMAB quarterly total liabilities has changed by -$246.00 K (-0.86%)